Sampling and Testing Method and Data Verification_BASE
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 561499 All Other Business Support Services
- Points of contact
-
- CDER Acquisition Liaison cderacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring contract subject matter experts to conduct a comprehensive internal audit of the drug quality sampling and testing database, with focus on data integrity, documentation compliance, and methodological consistency for import samples over fiscal years 2022–2025. The solicitation is estimated to release on February 1, 2027, with award anticipated on September 1, 2027.
The estimated award value ranges from $250,000 to $700,000. No set-aside applies. Questions and inquiries should be directed to the FDA Acquisition Liaison at cderacquisitions@fda.hhs.gov.
Forecast text
Engage contract subject matter experts to conduct a comprehensive internal audit of the drug quality sampling and testing database, examining data integrity, documentation compliance, and methodological consistency over the past four fiscal years with a focus on import samples (FY 2022-2025).
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast